# 2020 Liquid Biopsy for Cancer Gordon Research Conference and Seminar

> **NIH NIH R13** · GORDON RESEARCH CONFERENCES · 2020 · $1

## Abstract

Summary
This application seeks to support a Gordon Research Conference (GRC) and Gordon
Research Seminar (GRS) entitled “Liquid Biopsy for Cancer”.
The analysis of circulating tumor cells (CTCs) and tumor cell products (DNA, RNA,
extracellular vesicles) released into the blood may provide clinically-relevant information,
and can be collected using a non-invasive blood draw referred to as “liquid biopsy”.
Liquid biopsy analyses with highly sensitive and specific bioanalytical platforms provide
important information enabling early detection of cancer, identification of cancer patients
at risk to develop relapse (prognosis), and it may serve to monitor tumor evolution, identify
therapeutic targets or mechanisms of resistance on metastatic cells. Metastatic cells may
possess unique characteristics that can differ from the bulk of cancer cells in the primary
tumor currently used for stratification of patients to systemic therapy. Moreover,
monitoring of blood samples before, during and after systemic therapy (e.g.,
chemotherapy, targeted therapy or immunotherapy) can provide unique information for
the future clinical management of the individual cancer patient and might serve as
surrogate marker for response to therapy.
This conference will focus on the biology behind liquid biopsy biomarkers, new technical
developments and members of the liquid biopsy biomarker family and how liquid biopsy
analysis can be used to improve the management of cancer patients and contribute to
precision medicine.

## Key facts

- **NIH application ID:** 9994516
- **Project number:** 1R13CA250296-01
- **Recipient organization:** GORDON RESEARCH CONFERENCES
- **Principal Investigator:** Shana O Kelley
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1
- **Award type:** 1
- **Project period:** 2020-03-01 → 2022-01-04

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9994516

## Citation

> US National Institutes of Health, RePORTER application 9994516, 2020 Liquid Biopsy for Cancer Gordon Research Conference and Seminar (1R13CA250296-01). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/9994516. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*